Financials · mywealthgrid

Consolidated figures · ₹ crore

₹ Cr	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	957	805	930	815	1,011	949	974	805	980	1,041	995	938
COGS	354	317	367	295	384	359	352	288	356	364	344	328
Gross profit	603	488	563	519	626	590	622	517	624	677	651	611
	313	270	305	289	305	298	289	266	289	306	300	315
	289	218	257	231	322	292	333	251	336	371	351	296
OPM %	30.3%	27.1%	27.7%	28.3%	31.8%	30.8%	34.2%	31.2%	34.3%	35.7%	35.3%	31.5%
Depreciation	18	17	18	16	17	19	15	16	17	20	13	16
Interest	0	0	1	0	0	0	1	0	1	1	1	1
	28	-135	32	36	39	35	41	44	36	50	36	44
Profit before tax	299	65	271	249	344	308	359	279	354	400	373	322
Tax	82	20	76	67	91	78	96	74	97	104	95	85
Tax %	27.3%	30.1%	28.1%	26.9%	26.6%	25.4%	26.7%	26.5%	27.3%	26.1%	25.5%	26.4%
	218	46	194	182	253	230	263	205	257	296	278	237
PAT margin %	22.7%	5.7%	20.9%	22.4%	25%	24.2%	27%	25.5%	26.3%	28.4%	27.9%	25.3%
EPS (₹)	12.8	9.9	11.5	10.8	14.7	13.6	15.5	12.1	15.1	16.5	16.4	14
Results filing	—	—	—	—	—	—	—	Results filing for Jun 2025	Results filing for Sep 2025	Results filing for Dec 2025	Results filing for Mar 2026	Results filing for Jun 2026

vs same quarter last year	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue YoY %	+4.4%	+0.4%	+18.1%	+7%	+5.6%	+17.9%	+4.8%	-1.2%

Glaxosmithkline Pharmaceuticals Limited